Association between beta-2 adrenergic receptor variants and clinical outcomes in children and adolescents with acute asthma
- PMID: 35352766
- PMCID: PMC8932728
- DOI: 10.31744/einstein_journal/2022AO6412
Association between beta-2 adrenergic receptor variants and clinical outcomes in children and adolescents with acute asthma
Abstract
Objective: To investigate whether different genotypes of p.Arg16Gly, p.Gln27Glu, p.Arg19Cys and p.Thr164Ile variants interfere in response to treatment in children and adolescents with moderate to severe acute asthma.
Methods: This sample comprised patients aged 2 to 17 years with a history of at least two wheezing episodes and current moderate to severe asthma exacerbation. All patients received multiple doses of albuterol and ipratropium bromide delivered via pressurized metered-dose inhaler with holding chamber and systemic corticosteroids. Hospital admission was defined as the primary outcome. Secondary outcomes were changes in forced expiratory volume in the first second after 1 hour of treatment, and for outpatients, length of stay in the emergency room. Variants were genotyped by sequencing.
Results: A total of 60 patients were evaluated. Hospital admission rates were significantly higher in carriers of the genotype AA relative to those with genotype AG or GG, within the p.Arg16Gly variant (p=0.03, test χ2, alpha=0.05). Secondary outcomes did not differ between genotypes.
Conclusion: Hospital admission rates were significantly higher among carriers of the genotype AA within the p.Arg16Gly variant. Trial registration: ClinicalTrials.gov: NCT01323010.
Conflict of interest statement
Similar articles
-
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.Lancet Respir Med. 2014 Jan;2(1):44-53. doi: 10.1016/S2213-2600(13)70248-0. Epub 2013 Dec 5. Lancet Respir Med. 2014. PMID: 24461901 Clinical Trial.
-
A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers.J Emerg Med. 2018 Jul;55(1):7-14. doi: 10.1016/j.jemermed.2018.03.002. Epub 2018 Apr 30. J Emerg Med. 2018. PMID: 29716819 Clinical Trial.
-
Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.BMC Pulm Med. 2016 Apr 30;16(1):65. doi: 10.1186/s12890-016-0223-3. BMC Pulm Med. 2016. PMID: 27130202 Free PMC article. Clinical Trial.
-
A meta-analysis of the influence of ADRB2 genetic polymorphisms on albuterol (salbutamol) therapy in patients with asthma.Br J Clin Pharmacol. 2021 Apr;87(4):1708-1716. doi: 10.1111/bcp.14570. Epub 2020 Oct 25. Br J Clin Pharmacol. 2021. PMID: 32986886
-
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: A systematic review with meta-analysis.Pediatr Pulmonol. 2020 Dec;55(12):3268-3278. doi: 10.1002/ppul.25077. Epub 2020 Sep 25. Pediatr Pulmonol. 2020. PMID: 32940961
Cited by
-
Update on the Role of β2AR and TRPV1 in Respiratory Diseases.Int J Mol Sci. 2024 Sep 24;25(19):10234. doi: 10.3390/ijms251910234. Int J Mol Sci. 2024. PMID: 39408565 Free PMC article. Review.
-
Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans.Int J Hypertens. 2023 May 30;2023:9919677. doi: 10.1155/2023/9919677. eCollection 2023. Int J Hypertens. 2023. PMID: 38633331 Free PMC article. Review.
References
-
- . Global Innicaitive for Asthma. Global Strategy for Asthma Management and Prevention (2020 update). Fontana (WI): GINA; 2020 [cited 2020 Dez 12]. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_...
-
- . Healthcare Improvement Scotland. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 158. British guideline on the management of asthma. Edinburgh: SIGN; 2019 [cited 2020 Dec 11]. Available from: https://www.brit-thoracic.org.uk/document-library/guidelines/asthma/btss...
-
- . Pijnenburg MW, Fleming L. Advances in understanding and reducing the burden of severe asthma in children. Lancet Respir Med. 2020;8(10):1032-44. Review. - PubMed
-
- . Muchão FP, Souza JM, Torres HC, De Lalibera IB, de Souza AV, Rodrigues JC, et al. Albuterol via metered-dose inhaler in children: lower doses are effective, and higher doses are safe. Pediatr Pulmonol. 2016;51(11):1122-30. - PubMed